Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28066560 | 0.78 | TSHR (0.39) | TSHR | |
| SCHEMBL471726 | 0.77 | PDE4A (0.41) | — | |
| SCHEMBL817588 | 0.77 | PDE4A (0.41) | — | |
| SCHEMBL1478552 | 0.77 | PDE4A (0.41) | — | |
| SCHEMBL29720316 | 0.77 | PDE4A (0.41) | — | |
| SCHEMBL19912990 | 0.74 | TSHR (0.35) | TSHR | |
| SCHEMBL27570058 | 0.74 | — | — | |
| SCHEMBL16468880 | 0.70 | — | — | |
| SCHEMBL820016 | 0.70 | — | — | |
| SCHEMBL822534 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112852890-A | Biological synthesis method of polyhydroxy diketone and hydroxy furanone compound | 中国科学院天津工业生物技术研究所 | 2021-05-28 | — | — | CN | claimed |
| CN-115417755-A | Purification and cyclization process of 3, 4-dihydroxy-2, 5-hexanedione | 安徽金禾化学材料研究所有限公司 | 2022-12-02 | — | — | CN | disclosed |
| CN-112852890-A | Biological synthesis method of polyhydroxy diketone and hydroxy furanone compound | 中国科学院天津工业生物技术研究所 | 2021-05-28 | — | — | CN | disclosed |
| US-20120052028-A1 | CINNAMIC ACID ASCORBATES | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2012-03-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120052028-A1 | CINNAMIC ACID ASCORBATES | PROC, C1S, NISCH | GAPDH 1052/4885TSHR 4823/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.